A legitimate Canadian research peptide supplier operates within Canadian regulatory framing, maintains a registered business, and absorbs the costs of compliant operation business registration, tax remittance, insurance, payment processing, and customer support
Common brand names include Ozempic, Wegovy, Mounjaro, Saxenda, and Victoza
In order to limit GLP-1 costs and prioritize the cohorts most at risk, payers should develop a risk stratification rubric to segment and prioritize patients for GLP-1 weight loss coverage in cases where it is medically necessary and/or where cost of care can be lowered the most
Other GLP-1 drugs are completing trials for MASH and may be approved for it soon
Time of day has not been shown to affect the efficacy or safety of retatrutide
Glucagon is a hormone that raises blood sugar